Real-Time Beneficiary Drug Cost Bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Real-Time Beneficiary Drug Cost Bill
This bill provides statutory authority for certain provisions of the Centers for Medicare & Medicaid Services rule titled "Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses," published on May 23, 2019. The rule requires, in part, Medicare prescription drug plan sponsors to implement an electronic, real-time benefit tool that is capable of integrating with at least one prescriber's electronic prescribing system or electronic health record. The tool must provide prescribers with patient-specific, real-time formulary and benefit information, including information regarding cost-sharing, formulary alternatives, and utilization management requirements. The rule takes effect January 1, 2021.
Referred to the Subcommittee on Health.
- Introduced in House Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H.R. 3415: Real-Time Beneficiary Drug Cost Bill. 116th Congress. Open America. https://openamerica.io/bill/116-HR-3415/
"H.R. 3415: Real-Time Beneficiary Drug Cost Bill." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HR-3415/.
H.R. 3415, 116th Cong. (2026), https://openamerica.io/bill/116-HR-3415/.
[H.R. 3415: Real-Time Beneficiary Drug Cost Bill](https://openamerica.io/bill/116-HR-3415/)